HER2 Amplified Breast Cancer
1 clinical trials · Condition
◉ Watch HER2 Amplified Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib (NCT04366713) | Puma Biotechnology, Inc. | 2020-06-30 |
Track HER2 Amplified Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.